nuffield health Company Information
Company Number
00576970
Website
www.nuffieldhealth.comRegistered Address
epsom gateway ashley avenue, epsom, surrey, KT18 5AL
Industry
Other human health activities
Telephone
03001236200
Next Accounts Due
September 2025
Group Structure
View All
Shareholders
-0%
nuffield health Estimated Valuation
Pomanda estimates the enterprise value of NUFFIELD HEALTH at £1.1b based on a Turnover of £1.4b and 0.82x industry multiple (adjusted for size and gross margin).
nuffield health Estimated Valuation
Pomanda estimates the enterprise value of NUFFIELD HEALTH at £479.6m based on an EBITDA of £66.8m and a 7.18x industry multiple (adjusted for size and gross margin).
nuffield health Estimated Valuation
Pomanda estimates the enterprise value of NUFFIELD HEALTH at £2.6b based on Net Assets of £1.1b and 2.38x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Nuffield Health Overview
Nuffield Health is a live company located in surrey, KT18 5AL with a Companies House number of 00576970. It operates in the other human health activities sector, SIC Code 86900. Founded in January 1957, it's largest shareholder is unknown. Nuffield Health is a mature, mega sized company, Pomanda has estimated its turnover at £1.4b with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Nuffield Health Health Check
Pomanda's financial health check has awarded Nuffield Health a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
5 Strong
3 Regular
4 Weak
Size
annual sales of £1.4b, make it larger than the average company (£839.4k)
£1.4b - Nuffield Health
£839.4k - Industry AVG
Growth
3 year (CAGR) sales growth of 20%, show it is growing at a faster rate (6.4%)
20% - Nuffield Health
6.4% - Industry AVG
Production
with a gross margin of 13.5%, this company has a higher cost of product (33.9%)
13.5% - Nuffield Health
33.9% - Industry AVG
Profitability
an operating margin of -0.9% make it less profitable than the average company (5.6%)
-0.9% - Nuffield Health
5.6% - Industry AVG
Employees
with 18215 employees, this is above the industry average (20)
18215 - Nuffield Health
20 - Industry AVG
Pay Structure
on an average salary of £28.9k, the company has an equivalent pay structure (£26.1k)
£28.9k - Nuffield Health
£26.1k - Industry AVG
Efficiency
resulting in sales per employee of £74.6k, this is more efficient (£48.9k)
£74.6k - Nuffield Health
£48.9k - Industry AVG
Debtor Days
it gets paid by customers after 19 days, this is near the average (22 days)
19 days - Nuffield Health
22 days - Industry AVG
Creditor Days
its suppliers are paid after 18 days, this is close to average (16 days)
18 days - Nuffield Health
16 days - Industry AVG
Stock Days
it holds stock equivalent to 5 days, this is less than average (13 days)
5 days - Nuffield Health
13 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 2 weeks, this is less cash available to meet short term requirements (104 weeks)
2 weeks - Nuffield Health
104 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 43.6%, this is a higher level of debt than the average (26.2%)
43.6% - Nuffield Health
26.2% - Industry AVG
NUFFIELD HEALTH financials
Nuffield Health's latest turnover from December 2023 is £1.4 billion and the company has net assets of £1.1 billion. According to their latest financial statements, Nuffield Health has 18,215 employees and maintains cash reserves of £12 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 1,358,100,000 | 1,237,600,000 | 988,500,000 | 779,500,000 | 992,800,000 | 945,800,000 | 909,100,000 | 839,500,000 | 767,500,000 | 710,800,000 | 654,400,000 | 644,900,000 | 575,200,000 | 552,200,000 | 552,400,000 |
Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost Of Sales | 1,174,300,000 | 1,103,200,000 | 926,900,000 | 823,600,000 | 942,100,000 | 887,100,000 | 871,200,000 | 785,500,000 | 730,600,000 | 669,000,000 | 655,900,000 | 606,000,000 | 543,000,000 | 521,600,000 | 576,500,000 |
Gross Profit | 183,800,000 | 134,400,000 | 61,600,000 | -44,100,000 | 50,700,000 | 58,700,000 | 37,900,000 | 54,000,000 | 36,900,000 | 41,800,000 | -1,500,000 | 38,900,000 | 32,200,000 | 30,600,000 | -24,100,000 |
Admin Expenses | 76,900,000 | 30,000,000 | 48,600,000 | 41,800,000 | 43,700,000 | 34,300,000 | 24,400,000 | 22,400,000 | 19,300,000 | 11,700,000 | 2,500,000 | 8,700,000 | |||
Operating Profit | -15,300,000 | -74,100,000 | 2,100,000 | 16,900,000 | -5,800,000 | 19,700,000 | 12,500,000 | 19,400,000 | -20,800,000 | 20,500,000 | 28,100,000 | -32,800,000 | |||
Interest Payable | 46,300,000 | 6,500,000 | 17,500,000 | 18,700,000 | 17,600,000 | 18,700,000 | 19,200,000 | 16,500,000 | 16,600,000 | 29,600,000 | 16,800,000 | 18,700,000 | 17,700,000 | 17,900,000 | 12,200,000 |
Interest Receivable | 0 | 0 | 0 | 400,000 | 500,000 | 400,000 | 400,000 | 100,000 | 100,000 | 13,100,000 | 500,000 | 400,000 | 500,000 | 900,000 | 500,000 |
Pre-Tax Profit | -64,000,000 | -62,600,000 | -32,800,000 | -92,400,000 | -15,000,000 | -7,500,000 | -23,800,000 | 2,600,000 | -3,900,000 | 2,900,000 | -32,200,000 | 4,100,000 | 3,800,000 | 500,000 | -53,200,000 |
Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -200,000 | 0 | 0 | -100,000 | -400,000 | -300,000 |
Profit After Tax | -64,000,000 | -62,600,000 | -32,800,000 | -92,400,000 | -15,000,000 | -7,500,000 | -23,800,000 | 2,600,000 | -3,900,000 | 2,700,000 | -32,200,000 | 4,100,000 | 3,700,000 | 100,000 | -53,500,000 |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Profit | -64,100,000 | -62,900,000 | -32,900,000 | -92,400,000 | -15,000,000 | -7,500,000 | -23,800,000 | 2,600,000 | -3,900,000 | 2,700,000 | -32,200,000 | 4,100,000 | 3,700,000 | 100,000 | -53,500,000 |
Employee Costs | 526,100,000 | 485,800,000 | 400,200,000 | 372,300,000 | 391,200,000 | 363,300,000 | 343,500,000 | 311,800,000 | 274,400,000 | 246,800,000 | 221,400,000 | 218,500,000 | 197,300,000 | 182,900,000 | 187,600,000 |
Number Of Employees | 18,215 | 17,165 | 16,400 | 15,752 | 15,803 | 16,187 | 16,198 | 13,672 | 12,339 | 7,192 | 5,933 | 2,182 | 2,064 | 2,007 | 2,016 |
EBITDA* | 60,200,000 | 4,300,000 | 104,600,000 | 98,200,000 | 79,300,000 | 87,800,000 | 81,200,000 | 82,700,000 | 39,700,000 | 73,400,000 | 76,800,000 | 21,800,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 1,659,600,000 | 422,900,000 | 449,000,000 | 455,400,000 | 490,500,000 | 529,500,000 | 534,000,000 | 525,900,000 | 483,200,000 | 464,800,000 | 469,300,000 | 476,200,000 | 449,100,000 | 450,000,000 | 437,800,000 |
Intangible Assets | 86,800,000 | 101,600,000 | 117,100,000 | 109,300,000 | 101,200,000 | 88,400,000 | 103,600,000 | 108,600,000 | 53,200,000 | 43,600,000 | 21,700,000 | 43,900,000 | 43,700,000 | 53,100,000 | 38,200,000 |
Investments & Other | 13,000,000 | 15,100,000 | 4,700,000 | 200,000 | 200,000 | 400,000 | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | 3,700,000 | 400,000 | 400,000 | 2,800,000 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 1,759,400,000 | 539,600,000 | 570,800,000 | 564,900,000 | 591,900,000 | 618,300,000 | 637,800,000 | 634,700,000 | 536,600,000 | 508,600,000 | 491,200,000 | 523,800,000 | 493,200,000 | 503,500,000 | 478,800,000 |
Stock & work in progress | 18,100,000 | 17,300,000 | 15,800,000 | 10,500,000 | 10,300,000 | 9,800,000 | 9,300,000 | 8,700,000 | 8,100,000 | 7,500,000 | 7,400,000 | 7,300,000 | 7,000,000 | 8,000,000 | 8,400,000 |
Trade Debtors | 71,400,000 | 68,900,000 | 51,000,000 | 33,200,000 | 53,600,000 | 52,000,000 | 52,600,000 | 57,100,000 | 50,400,000 | 46,400,000 | 43,000,000 | 46,500,000 | 44,600,000 | 49,500,000 | 41,700,000 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 57,500,000 | 50,000,000 | 57,000,000 | 68,500,000 | 37,500,000 | 33,900,000 | 34,400,000 | 39,400,000 | 22,500,000 | 26,300,000 | 30,000,000 | 26,900,000 | 21,600,000 | 25,400,000 | 28,300,000 |
Cash | 12,000,000 | 17,900,000 | 8,800,000 | 7,100,000 | 4,400,000 | 2,400,000 | 3,200,000 | 2,900,000 | 3,300,000 | 13,800,000 | 12,700,000 | 17,200,000 | 12,800,000 | 9,100,000 | 6,600,000 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 800,000 | 700,000 | 700,000 | 400,000 | 700,000 |
total current assets | 159,000,000 | 154,100,000 | 132,600,000 | 119,300,000 | 105,800,000 | 98,100,000 | 99,500,000 | 108,100,000 | 84,300,000 | 94,000,000 | 93,900,000 | 98,600,000 | 86,700,000 | 92,400,000 | 85,700,000 |
total assets | 1,918,400,000 | 693,700,000 | 703,400,000 | 684,200,000 | 697,700,000 | 716,400,000 | 737,300,000 | 742,800,000 | 620,900,000 | 602,600,000 | 585,100,000 | 622,400,000 | 579,900,000 | 595,900,000 | 564,500,000 |
Bank overdraft | 13,000,000 | 9,700,000 | 0 | 0 | 0 | 3,200,000 | 0 | 0 | 5,000,000 | 0 | 0 | 0 | 0 | 900,000 | 0 |
Bank loan | 10,000,000 | 0 | 324,100,000 | 0 | 0 | 0 | 0 | 0 | 0 | 500,000 | 9,000,000 | 0 | 0 | 9,500,000 | 100,000 |
Trade Creditors | 59,300,000 | 26,300,000 | 22,100,000 | 45,600,000 | 42,200,000 | 34,600,000 | 43,800,000 | 45,100,000 | 27,500,000 | 39,600,000 | 25,700,000 | 30,000,000 | 25,700,000 | 17,500,000 | 10,900,000 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 1,900,000 | 7,700,000 | 0 | 700,000 | 0 | 0 | 18,700,000 | 0 | 0 | 400,000 | 1,200,000 | 6,600,000 | 2,200,000 | 21,000,000 | 0 |
hp & lease commitments | 400,000 | 800,000 | 2,700,000 | 3,000,000 | 2,700,000 | 2,100,000 | 2,000,000 | 1,900,000 | 1,900,000 | 3,000,000 | 3,000,000 | 3,100,000 | 1,800,000 | 2,100,000 | 300,000 |
other current liabilities | 156,000,000 | 182,200,000 | 191,200,000 | 142,200,000 | 116,100,000 | 118,400,000 | 103,000,000 | 113,800,000 | 118,300,000 | 93,300,000 | 94,600,000 | 82,200,000 | 70,100,000 | 71,800,000 | 63,100,000 |
total current liabilities | 240,600,000 | 226,700,000 | 540,100,000 | 191,500,000 | 161,000,000 | 158,300,000 | 167,500,000 | 160,800,000 | 152,700,000 | 136,800,000 | 133,500,000 | 121,900,000 | 99,800,000 | 122,800,000 | 74,400,000 |
loans | 466,300,000 | 444,300,000 | 100,000,000 | 404,100,000 | 367,100,000 | 361,900,000 | 363,800,000 | 361,500,000 | 268,800,000 | 255,700,000 | 223,200,000 | 237,900,000 | 216,800,000 | 209,100,000 | 217,000,000 |
hp & lease commitments | 1,800,000 | 100,000 | 0 | 2,200,000 | 5,100,000 | 4,800,000 | 6,500,000 | 4,300,000 | 1,300,000 | 2,800,000 | 4,900,000 | 7,400,000 | 5,200,000 | 6,600,000 | 700,000 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,700,000 | 0 | 0 | 0 | 0 |
other liabilities | 4,600,000 | 4,500,000 | 4,900,000 | 2,700,000 | 3,100,000 | 3,300,000 | 3,500,000 | 3,700,000 | 3,600,000 | 2,700,000 | 2,000,000 | 0 | 4,200,000 | 1,400,000 | 2,300,000 |
provisions | 83,000,000 | 77,800,000 | 46,000,000 | 35,500,000 | 21,500,000 | 33,500,000 | 35,700,000 | 29,200,000 | 12,300,000 | 14,900,000 | 9,500,000 | 7,500,000 | 6,200,000 | 6,800,000 | 8,200,000 |
total long term liabilities | 596,600,000 | 571,400,000 | 217,900,000 | 569,200,000 | 498,200,000 | 493,900,000 | 505,600,000 | 520,000,000 | 366,300,000 | 385,600,000 | 334,000,000 | 359,600,000 | 317,300,000 | 298,900,000 | 306,100,000 |
total liabilities | 837,200,000 | 798,100,000 | 758,000,000 | 760,700,000 | 659,200,000 | 652,200,000 | 673,100,000 | 680,800,000 | 519,000,000 | 522,400,000 | 467,500,000 | 481,500,000 | 417,100,000 | 421,700,000 | 380,500,000 |
net assets | 1,080,600,000 | -104,900,000 | -55,300,000 | -76,500,000 | 38,400,000 | 64,100,000 | 64,100,000 | 61,900,000 | 101,900,000 | 80,200,000 | 117,600,000 | 140,900,000 | 162,800,000 | 174,200,000 | 184,000,000 |
total shareholders funds | 1,080,600,000 | -104,900,000 | -55,300,000 | -76,500,000 | 38,400,000 | 64,100,000 | 64,100,000 | 61,900,000 | 101,900,000 | 80,200,000 | 117,600,000 | 140,900,000 | 162,800,000 | 174,200,000 | 184,000,000 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | -15,300,000 | -74,100,000 | 2,100,000 | 16,900,000 | -5,800,000 | 19,700,000 | 12,500,000 | 19,400,000 | -20,800,000 | 20,500,000 | 28,100,000 | -32,800,000 | |||
Depreciation | 57,900,000 | 51,700,000 | 54,400,000 | 52,300,000 | 74,000,000 | 55,200,000 | 61,900,000 | 54,700,000 | 51,800,000 | 57,900,000 | 55,800,000 | 51,600,000 | 47,100,000 | 45,000,000 | 50,600,000 |
Amortisation | 21,300,000 | 21,100,000 | 21,100,000 | 26,100,000 | 28,500,000 | 26,100,000 | 23,200,000 | 13,400,000 | 16,900,000 | 5,400,000 | 4,700,000 | 5,900,000 | 5,800,000 | 3,700,000 | 4,000,000 |
Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -200,000 | 0 | 0 | -100,000 | -400,000 | -300,000 |
Stock | 800,000 | 1,500,000 | 5,300,000 | 200,000 | 500,000 | 500,000 | 600,000 | 600,000 | 600,000 | 100,000 | 100,000 | 300,000 | -1,000,000 | -400,000 | 8,400,000 |
Debtors | 10,000,000 | 10,900,000 | 6,300,000 | 10,600,000 | 5,200,000 | -1,100,000 | -9,500,000 | 23,600,000 | 200,000 | -300,000 | -400,000 | 7,200,000 | -8,700,000 | 4,900,000 | 70,000,000 |
Creditors | 33,000,000 | 4,200,000 | -23,500,000 | 3,400,000 | 7,600,000 | -9,200,000 | -1,300,000 | 17,600,000 | -12,100,000 | 13,900,000 | -4,300,000 | 4,300,000 | 8,200,000 | 6,600,000 | 10,900,000 |
Accruals and Deferred Income | -26,200,000 | -9,000,000 | 49,000,000 | 26,100,000 | -2,300,000 | 15,400,000 | -10,800,000 | -4,500,000 | 25,000,000 | -4,000,000 | 15,100,000 | 12,100,000 | -1,700,000 | 8,700,000 | 63,100,000 |
Deferred Taxes & Provisions | 5,200,000 | 31,800,000 | 10,500,000 | 14,000,000 | -12,000,000 | -2,200,000 | 6,500,000 | 16,900,000 | -2,600,000 | 5,400,000 | 2,000,000 | 1,300,000 | -600,000 | -1,400,000 | 8,200,000 |
Cash flow from operations | 84,600,000 | 37,000,000 | 92,200,000 | 102,800,000 | 82,600,000 | 93,600,000 | 90,700,000 | 98,000,000 | 52,800,000 | 88,900,000 | 85,800,000 | 25,300,000 | |||
Investing Activities | |||||||||||||||
capital expenditure | 0 | 0 | 0 | 0 | 0 | -57,800,000 | -95,300,000 | -154,200,000 | 0 | 0 | -69,200,000 | -52,000,000 | -39,600,000 | -27,300,000 | -27,900,000 |
Change in Investments | -2,100,000 | 10,400,000 | 4,500,000 | 0 | -200,000 | 200,000 | 0 | 0 | 0 | 0 | -3,500,000 | 3,300,000 | 0 | -2,400,000 | 2,800,000 |
cash flow from investments | 2,100,000 | -10,400,000 | -4,500,000 | 0 | 200,000 | -58,000,000 | -95,300,000 | -154,200,000 | 0 | 0 | -65,700,000 | -55,300,000 | -39,600,000 | -24,900,000 | -30,700,000 |
Financing Activities | |||||||||||||||
Bank loans | 10,000,000 | -324,100,000 | 324,100,000 | 0 | 0 | 0 | 0 | 0 | -500,000 | -8,500,000 | 9,000,000 | 0 | -9,500,000 | 9,400,000 | 100,000 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | -5,800,000 | 7,700,000 | -700,000 | 700,000 | 0 | -18,700,000 | 18,700,000 | 0 | -400,000 | -800,000 | -5,400,000 | 4,400,000 | -18,800,000 | 21,000,000 | 0 |
Long term loans | 22,000,000 | 344,300,000 | -304,100,000 | 37,000,000 | 5,200,000 | -1,900,000 | 2,300,000 | 92,700,000 | 13,100,000 | 32,500,000 | -14,700,000 | 21,100,000 | 7,700,000 | -7,900,000 | 217,000,000 |
Hire Purchase and Lease Commitments | 1,300,000 | -1,800,000 | -2,500,000 | -2,600,000 | 900,000 | -1,600,000 | 2,300,000 | 3,000,000 | -2,600,000 | -2,100,000 | -2,600,000 | 3,500,000 | -1,700,000 | 7,700,000 | 1,000,000 |
other long term liabilities | 100,000 | -400,000 | 2,200,000 | -400,000 | -200,000 | -200,000 | -200,000 | 100,000 | 900,000 | 700,000 | 2,000,000 | -4,200,000 | 2,800,000 | -900,000 | 2,300,000 |
share issue | |||||||||||||||
interest | -46,300,000 | -6,500,000 | -17,500,000 | -18,300,000 | -17,100,000 | -18,300,000 | -18,800,000 | -16,400,000 | -16,500,000 | -16,500,000 | -16,300,000 | -18,300,000 | -17,200,000 | -17,000,000 | -11,700,000 |
cash flow from financing | 1,230,900,000 | 32,500,000 | 55,600,000 | -6,100,000 | -21,900,000 | -33,200,000 | 30,300,000 | 36,800,000 | 19,600,000 | -34,800,000 | -19,100,000 | -19,500,000 | -51,800,000 | 2,400,000 | 446,200,000 |
cash and cash equivalents | |||||||||||||||
cash | -5,900,000 | 9,100,000 | 1,700,000 | 2,700,000 | 2,000,000 | -800,000 | 300,000 | -400,000 | -10,500,000 | 1,100,000 | -4,500,000 | 4,400,000 | 3,700,000 | 2,500,000 | 6,600,000 |
overdraft | 3,300,000 | 9,700,000 | 0 | 0 | -3,200,000 | 3,200,000 | 0 | -5,000,000 | 5,000,000 | 0 | 0 | 0 | -900,000 | 900,000 | 0 |
change in cash | -9,200,000 | -600,000 | 1,700,000 | 2,700,000 | 5,200,000 | -4,000,000 | 300,000 | 4,600,000 | -15,500,000 | 1,100,000 | -4,500,000 | 4,400,000 | 4,600,000 | 1,600,000 | 6,600,000 |
nuffield health Credit Report and Business Information
Nuffield Health Competitor Analysis
Perform a competitor analysis for nuffield health by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mega companies, companies in KT18 area or any other competitors across 12 key performance metrics.
nuffield health Ownership
NUFFIELD HEALTH group structure
Nuffield Health has 17 subsidiary companies.
Ultimate parent company
NUFFIELD HEALTH
00576970
17 subsidiaries
nuffield health directors
Nuffield Health currently has 10 directors. The longest serving directors include Dr Natalie-Jane MacDonald (Jan 2017) and Mr Stephen Maslin (Jul 2017).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Natalie-Jane MacDonald | 62 years | Jan 2017 | - | Director | |
Mr Stephen Maslin | 67 years | Jul 2017 | - | Director | |
Mr Patrick Figgis | England | 67 years | Jun 2018 | - | Director |
Lord Victor Adebowale | England | 62 years | Jun 2019 | - | Director |
Dr Junaid Bajwa | England | 44 years | Sep 2021 | - | Director |
Mr Mark Stansfeld | United Kingdom | 64 years | Oct 2021 | - | Director |
Ms Elizabeth Robb | United Kingdom | 71 years | Oct 2022 | - | Director |
Ms Tracey Killen | United Kingdom | 63 years | Jul 2023 | - | Director |
Mr Lee Rochford | 57 years | Jul 2023 | - | Director | |
Ms Karen Whitworth | United Kingdom | 55 years | Sep 2023 | - | Director |
P&L
December 2023turnover
1.4b
+10%
operating profit
-12.4m
0%
gross margin
13.6%
+24.62%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
1.1b
-11.3%
total assets
1.9b
+1.77%
cash
12m
-0.33%
net assets
Total assets minus all liabilities
nuffield health company details
company number
00576970
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
January 1957
age
67
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2023
previous names
nuffield hospitals (May 2008)
nuffield nursing homes trust (September 2003)
accountant
-
auditor
DELOITTE LLP
address
epsom gateway ashley avenue, epsom, surrey, KT18 5AL
Bank
BARCLAYS BANK PLC
Legal Advisor
CMS CAMERON MCKENNA
nuffield health Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 85 charges/mortgages relating to nuffield health. Currently there are 11 open charges and 74 have been satisfied in the past.
nuffield health Companies House Filings - See Documents
date | description | view/download |
---|